Belviq: Ndondomeko, Zotsatira Zotsatira ndi Zowonjezera

Phunzirani Mtengo wa BELVIQ Popanda Inshuwalansi

BELVIQ (lorcaserin) ndi mankhwala olemera omwe amavomerezedwa ndi Food and Drug Administration (FDA). Ngati muli ochepa kwambiri kapena onenepa kwambiri ndipo muli ndi matenda okhudzana ndi kulemera, zingakuthandizeni kuchepetsa thupi. Koma zotsatira za BELVIQ ndi mtengo wa BELVIQ uyenera kuganiziridwa musanaganize ngati mapiritsi a zakudya ndi abwino kwa inu.

Momwe BELVIQ imagwirira ntchito

BELVIQ ndi BELVIQ XR (kumasulidwa kwowonjezereka) ndizovomerezedwa ndi FDA kuti zigwiritsidwe ntchito kwa akuluakulu omwe ali ndi BMI ya makumi atatu ndi kupitirira, kapena kwa anthu omwe ali ndi chiwerengero cha anthu osachepera 27 ndipo ali ndi vuto limodzi lolemera ngati magazi kupanikizika, mtundu wa shuga 2, kapena cholesterol.

BELVIQ yapangidwa kuti ikuthandizeni kuti mukhale okhutira mutadya chakudya chochepa. Mankhwalawa amapangitsa serotonin receptors mu ubongo wanu. Serotonin receptors amalamulira njala. Pamene amavomereza kuti thupi lanu likhale lamphumphu, mukhoza kudya pang'ono ndi kuchepa thupi.

Kufotokozera zambiri za BELVIQ kumafotokoza kuti ogwiritsa ntchito mapiritsi 10 milligram kawiri patsiku limodzi ndi pulogalamu yochepa ya zakudya ndi zochita masewera olimbitsa thupi. Malingana ndi FDA, mankhwalawa ayenera kutengedwa kuti moyo wonse wa wodwalayo ukhale wolemera . BELVIQ sayenera kutengedwa ndi amayi omwe ali ndi mimba kapena akuyamwitsa.

Kodi ndilemera kotani komwe ndingataya pa BELVIQ?

M'mayesero am'chipatala, ofufuza anafufuza oposa 8000 oposa overweight ndi odwala kwambiri. Kuchuluka kwa kulemera komwe kunatayika pakati pa maphunzirowa kunali 3 mpaka 3.7% a kulemera kwake kwa thupi lonse. Pafupifupi 47% a odwala matenda a shuga anagonjetsa osachepera 5% a thupi lawo lonse, poyerekeza ndi 23% odwala omwe anatenga maloboti.

Mwachitsanzo, ngati panopa mukulemera mapaundi 250, zingakhale zomveka kuyembekezera kuti mutaya pakati pa 7.5 ndi 12.5 mapaundi mukatenga mankhwala a BELVI ndi zakudya komanso masewera olimbitsa thupi. Ngakhale kuti izi siziwoneka ngati zolemetsa zazikulu, odwala ena akhoza kupeza ubwino wathanzi mwa kutayika pang'ono.

Centers for Disease Control amanenanso kuti kutaya kwa 5% mpaka 10 peresenti ya kulemera kwanu kwa thupi kungapereke ubwino wathanzi monga kusintha kwa magazi, cholesterol ya magazi, ndi shuga la magazi.

Ngati simutayika kulemera kwanu kwa 5% mkati mwa masabata 12 oyambirira pa BELVIQ, sizingakhale kuti mankhwalawa akugwira ntchito kwa inu, ndipo dokotala wanu akhoza kukuchotsani mankhwala.

BELVIQ Zotsatira Zowopsya ndi Ngozi

Malingana ndi FDA, zotsatira zoyamba za BELVIQ zimaphatikizapo mutu, chizungulire, kutopa, kunyowa, pakamwa, ndi kudzimbidwa. Odwala matenda a shuga, zotsatira zake ndi shuga wochepa wa magazi (hypoglycemia), mutu, kupweteka kumbuyo, chifuwa, ndi kutopa. National Institutes of Health imapereka mndandanda wa zotsatira zomwe muyenera kuyesa ndikukambirana ndi adokotala musanayambe kumwa mankhwala. Mankhwalawa samavomerezedwa kwa odwala omwe awonapo zochitika ku lorcaserin kapena ku zigawo zina zapadera m'mbuyomo.

Kumayambiriro koyeso, ochita kafukufuku anali kudera nkhaŵa zokhudzana ndi mtima wa odwala omwe amatenga BELVIQ. Koma a FDA adapeza kuti mankhwalawa sangawathandize kuthetsa mavuto a mtima wa valve omwe adakalipo m'maphunziro oyambirira. Komabe, bungwe la BELVIQ silinaphunzirepo kwa odwala omwe ali ndi matenda a mtima a valvular ndipo FDA imalimbikitsa kuti odwala omwe ali ndi mtima wokhudzidwa mtima asamale kwambiri akamamwa mankhwala.

Kuonjezera apo, malinga ndi a New England Journal of Medicine pali nkhawa zina kuti mankhwalawa akhoza kutenga vuto la matenda a maganizo, makamaka kwa anthu amene akumwa mankhwala enaake. Malinga ndi a FDA, ogwiritsa ntchito a BELVIQ angakhale ndi matenda a serotonin, makamaka ngati atengedwa ndi mankhwala omwe amachititsa ma serotonin kapena omwe amachititsa serotonin receptors. Izi zikuphatikizapo mankhwala omwe amagwiritsidwa ntchito pochiza matenda ndi mutu wa mutu wa migraine. Lorcaserin ingayambitsenso kusokoneza maganizo kapena kukumbukira.

Belviq Mtengo ndi Inshuwalansi

Mukawerenga mtengo wanu wa BELVIQ, muyenera kukumbukira kuti mlingo malinga ndi FDA ndi mapiritsi awiri patsiku.

Choncho odwala ambiri amafuna mapiritsi 60 pamwezi. Muyeneranso kukumbukira kuti ngati mukufuna kuti mukhalebe wolemera, muyenera kukhala pa BELVIQ ndipo ndikupitirizabe kulipira mankhwala.

Mtengo wa BELVIQ umasinthasintha malinga ndi inshuwalansi ndi piritsi yomwe mumatenga (BELVIQ kapena BELVIQ XR). Ngati muli ndi inshuwalansi ya zachipatala yomwe imakhudza mtengo wa mankhwala, ndiye kuti mtengo wanu tsiku lililonse ukhoza kuthamanga madola 2 tsiku lililonse kwa BELVIQ XR ndi $ 2.20 patsiku la BELVIQ ndi makadi osunga ndalama omwe alipo pa makampani a webusaitiyi.

Ngati mulibe inshuwalansi kwa mankhwala, mukhoza kuyembekezera kulipira zambiri. Pafupifupi mtengo wa BELVIQ wopanda thandizo uli pafupi ndi $ 3.20 patsiku.

Kodi BELVIQ Ili Pamanja Kwa Inu?

Mankhwalawa sali ovomerezeka chifukwa cha "kuperewera kwachabechabe." Izi zikutanthauza kuti mapiritsi a zakudya sayenera kugwiritsidwa ntchito kwa anthu amene amafuna kuti aziwoneka bwino kuposa ma jeans omwe amawakonda. Ndithudi, pali ndalama zofunika kuziganizira ngati mukufuna kutenga ABVIQ. Ndemanga zingapo zovuta za BELVIQ zatchula za mndandanda wautali wa zotsatira zake ndi kuchepa kwazing'ono zomwe zingakuthandizeni kutaya. Koma ngati mwayesa njira zina zolemetsa popanda kupambana, mungafunike kukambirana ndi BELVIQ ndi dokotala wanu. Onetsetsani kuti mukuyezetsa zoopsa ndi zopindulitsa pamene mukuyankhula ndi wothandizira zaumoyo kuti mupange chisankho chabwino kwambiri cha mankhwala ndi moyo wanu.

Zotsatira:

> Arena Mankhwala . Arena Mankhwala ndi Eisai Akulengeza FDA Kuvomerezeka kwa BELVIQ® (lorcaserin HCl) ya Matenda Osalepheretsa Kulemera kwa Okalamba omwe ali olemera kwambiri omwe ali ndi Comorbidity kapena Obese.

Zomwe Zimayambitsa Matenda. Kulemera kwabwino - si chakudya, ndi moyo! http://www.cdc.gov/healthyweight/losing_weight/index.html

Eric Colman, MD, Julie Golden, MD, Mary Roberts, MD, Amy Egan, MD, MPH, Joyce Weaver, Pharm.D., Ndi Curtis Rosebraugh, MD, MPH. "Dongosolo la FDA la Zida Zachiwiri Zopangira Matenda Olemera." New England Journal of Medicine October 25, 2012.

Chakudya ndi Mankhwala Osokoneza Bongo. Mankhwala Amafunika Kuteteza Kulemera Kwambiri Kwambiri. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm312380.htm

Chakudya ndi Mankhwala Osokoneza Bongo. FDA imavomereza Belviq kuti athetse anthu ena okalamba kwambiri kapena olemera kwambiri. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm309993.htm

Akufuna Alpha. Kuyeza Belviq wa Arena Monga Mankhwala Osokoneza Bongo. http://seekingalpha.com/article/1059621-assessing-arenas-belviq-as-a-diabesity-drug